Dr. Elvin Geng joined the Department of Medicine in the Division of Infectious Diseases as a Professor on July 1, 2019.
Dr. Geng earned MD and MPH degrees from Columbia University and subsequently completed post-doctoral training through the Aaron Diamond AIDS Institute (posted in Kunming, China) as well as fellowship training in infectious diseases at the University of California in San Francisco. Since 2009, he has been a faculty member in the Department of Medicine, Division of HIV/AIDS, Infectious Diseases and Global Medicine at University of California at San Francisco, where he was most recently an Associate Professor of Medicine.
Using the lens of implementation science, he conducts research to optimize the use of evidence-based interventions in the public health response to human immunodeficiency virus (HIV) infection. Currently, through diverse collaborations in Kenya, Zambia, Uganda, as well as in safety net setting in the United States, he is leading work to advance strategies for HIV treatment success. This work includes assessing the comparative implementability and effectiveness of community-based and other innovative models for HIV treatment, testing adaptive strategies for engagement in HIV treatment, and using the patient experience to drive health systems improvement. Dr. Geng’s work makes use of a range of methods, including stepped-wedge cluster randomized trials, sequential multiple assignment randomized trials, choice experiments, as well observational and qualitative methods. His work is sponsored by the Bill and Melinda Gates Foundation and the National Institutes of Health. He serves in an advisory capacity for the World Health Organization, non-governmental organizations, and professional organizations. He is the author of over 125 peer-reviewed papers and is an academic editor at PLOS Medicine, a member of the editorial board of the Journal of the Acquired Immunodeficiency Syndrome and editor for implementation science at Current HIV/AIDS Reports.